Ghent University Academic Bibliography

Journal Article
A1
open access

On-target pharmacodynamic activity of the PI3K inhibitor copanlisib in paired biopsies from patients with malignant lymphoma and advanced solid tumors

Franck Morschhauser, Jean-Pascal Machiels, Gilles Salles, Sylvie Rottey (UGent) , Simon A. J. Rule, David Cunningham, Frederic Peyrade, Christophe Fruchart, Hendrik-Tobias Arkenau, Isabelle Genvresse, et al.

(2020) MOLECULAR CANCER THERAPEUTICS. 19(2). p.468-478

Add to list

Journal Article
A1
open access

Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

Jan A. Burger, Paul M. Barr, Tadeusz Robak, Carolyn Owen, Paolo Ghia, Alessandra Tedeschi, Osnat Bairey, Peter Hillmen, Steven E. Coutre, Stephen Devereux, et al.

(2020) LEUKEMIA. 34(3). p.787-798

Add to list

Analysis of DNA methylation in cancer : location revisited

Alexander Koch, Sophie C Joosten, Zheng Feng, Tim C de Ruijter, Muriel X Draht, Veerle Melotte, Kim M Smits, Jurgen Veeck, James G Herman, Leander Van Neste, et al.

(2018) NATURE REVIEWS CLINICAL ONCOLOGY. 15(7). p.459-466

Add to list

The phase 3 DUO trial : duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

Ian W Flinn, Peter Hillmen, Marco Montillo, Zsolt Nagy, Arpad Illes, Gabriel Etienne, Julio Delgado, Bryone J Kuss, Constantine S Tam, Zoltan Gasztonyi, et al.

(2018) BLOOD. 132(23). p.2446-2455

Add to list

Journal Article
A1
open access

Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia

S. Degryse, C. E. de Bock, S. Demeyer, I. Govaerts, S. Bornschein, D. Verbeke, K. Jacobs, S. Binos, D. A. Skerrett-Byrne, H. C. Murray, et al.

(2018) LEUKEMIA. 32(3). p.788-800

Add to list

Fight fire with fire : gene therapy strategies to cure HIV

Jon Huyghe (UGent) , Magdalena Sips (UGent) and Linos Vandekerckhove (UGent)

(2017) EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. 15(8). p.747-758

Add to list

Journal Article
A1
open access

Digital multiplex ligation-dependent probe amplification for detection of key copy number alterations in T- and B-cell lymphoblastic leukemia

Anne Benard-Slagter, Ilse Zondervan, Karel de Groot, Farzaneh Ghazavi (UGent) , Virinder Sarhadi, Pieter Van Vlierberghe (UGent) , Barbara De Moerloose (UGent) , Claire Schwab, Kim Vettenranta, Christine J Harrison, et al.

(2017) JOURNAL OF MOLECULAR DIAGNOSTICS. 19(5). p.659-672

Add to list

Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia

Sofie Peirs (UGent) , V Frismantas, Filip Matthijssens (UGent) , W Van Loocke, Tim Pieters (UGent) , Niels Vandamme (UGent) , Béatrice Lintermans (UGent) , MP Dobay, Geert Berx (UGent) , Bruce Poppe (UGent) , et al.

(2017) LEUKEMIA. 31(10). p.2037-2047

Add to list

Long non-coding RNAs in leukemia : biology and clinical impact

Tim Lammens (UGent) , Kaat Durinck (UGent) , Annelynn Wallaert (UGent) , Franki Speleman (UGent) and Pieter Van Vlierberghe (UGent)

(2017) CURRENT OPINION IN HEMATOLOGY. 24(4). p.353-358

Add to list

Journal Article
A1
open access

RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia

Daniel B Lipka, Tania Witte, Reka Toth, Jing Yang, Manuel Wiesenfarth, Peter Noellke, Alexandra Fischer, David Brocks, Zuguang Gu, Jeongbin Park, et al.

(2017) NATURE COMMUNICATIONS. 8.

Academic Bibliography

On-target pharmacodynamic activity of the PI3K inhibitor copanlisib in paired biopsies from patients with malignant lymphoma and advanced solid tumors

Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

Analysis of DNA methylation in cancer : location revisited

The phase 3 DUO trial : duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia

Fight fire with fire : gene therapy strategies to cure HIV

Digital multiplex ligation-dependent probe amplification for detection of key copy number alterations in T- and B-cell lymphoblastic leukemia

Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia

Long non-coding RNAs in leukemia : biology and clinical impact

RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia

Contents

Support

Contact